Cargando…

A Highly Effective System for Predicting MHC-II Epitopes With Immunogenicity

In the past decade, the substantial achievements of therapeutic cancer vaccines have shed a new light on cancer immunotherapy. The major challenge for designing potent therapeutic cancer vaccines is to identify neoantigens capable of inducing sufficient immune responses, especially involving major h...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Shi, Wang, Xiaohua, Fei, Caiyi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9246415/ https://www.ncbi.nlm.nih.gov/pubmed/35785204 http://dx.doi.org/10.3389/fonc.2022.888556

Ejemplares similares

Computational mining of MHC class II epitopes for the development of universal immunogenic proteins
por: Saylor, Kyle, et al.
Publicado: (2022)

Structural Properties of MHC Class II Ligands, Implications for the Prediction of MHC Class II Epitopes
por: Jørgensen, Kasper Winther, et al.
Publicado: (2010)

Improved MHC II epitope prediction — a step towards personalized medicine
por: Moore, Tamson V., et al.
Publicado: (2019)

The immunogenicity of a viral cytotoxic T cell epitope is controlled by its MHC-bound conformation
por: Tynan, Fleur E., et al.
Publicado: (2005)

Integrative Analysis of HTNV Glycoprotein Derived MHC II Epitopes by In Silico Prediction and Experimental Validation
por: Sun, Hao, et al.
Publicado: (2021)

Towards Universal Structure-Based Prediction of Class II MHC Epitopes for Diverse Allotypes
por: Bordner, Andrew J.
Publicado: (2010)

Predicting MHC class I epitopes in large datasets
por: Roomp, Kirsten, et al.
Publicado: (2010)

Influence of DM-sensitivity on immunogenicity of MHC class II restricted antigens
por: Bernhardt, Anna Luise, et al.
Publicado: (2021)

Expanding the MAPPs Assay to Accommodate MHC-II Pan Receptors for Improved Predictability of Potential T Cell Epitopes
por: Hartman, Katharina, et al.
Publicado: (2023)

Evaluating the Immunogenicity of Protein Drugs by Applying In Vitro MHC Binding Data and the Immune Epitope Database and Analysis Resource
por: Paul, Sinu, et al.
Publicado: (2013)

HLA-DO as the Optimizer of Epitope Selection for MHC Class II Antigen Presentation
por: Poluektov, Yuri O., et al.
Publicado: (2013)

Epitopes associated with MHC restriction site of T cells. III. I-J epitope on MHC-restricted T helper cells
Publicado: (1987)

NNAlign_MA; MHC Peptidome Deconvolution for Accurate MHC Binding Motif Characterization and Improved T-cell Epitope Predictions
por: Alvarez, Bruno, et al.
Publicado: (2019)

Customized Predictions of Peptide–MHC Binding and T-Cell Epitopes Using EPIMHC
por: Molero-Abraham, Magdalena, et al.
Publicado: (2014)

A novel Minimalist Cell-Free MHC Class II Antigen Processing System Identifies Immunodominant Epitopes
por: Hartman, Isamu Z., et al.
Publicado: (2010)

Predicting Hemagglutinin MHC-II Ligand Analogues in Anti-TNFα Biologics: Implications for Immunogenicity of Pharmaceutical Proteins
por: Andrick, Benjamin J., et al.
Publicado: (2015)

GPS-MBA: Computational Analysis of MHC Class II Epitopes in Type 1 Diabetes
por: Cai, Ruikun, et al.
Publicado: (2012)

Endogenous Antigen Presentation of MHC Class II Epitopes through Non-Autophagic Pathways
por: Leung, Carol S. K.
Publicado: (2015)

Yeast display platform with expression of linear peptide epitopes for high-throughput assessment of peptide-MHC-II binding
por: Huisman, Brooke D., et al.
Publicado: (2023)

Benchmarking predictions of MHC class I restricted T cell epitopes in a comprehensively studied model system
por: Paul, Sinu, et al.
Publicado: (2020)

Epitopes associated with the MHC restriction site of T cells. II. Somatic generation of Iat epitopes on T cells in radiation bone marrow chimeras
Publicado: (1987)

Combined assessment of MHC binding and antigen abundance improves T cell epitope predictions
por: Koşaloğlu-Yalçın, Zeynep, et al.
Publicado: (2022)

NetCTLpan: pan-specific MHC class I pathway epitope predictions
por: Stranzl, Thomas, et al.
Publicado: (2010)

Correction: GPS-MBA: Computational Analysis of MHC Class II Epitopes in Type 1 Diabetes
por: Cai, Ruikun, et al.
Publicado: (2012)

A combination of epitope prediction and molecular docking allows for good identification of MHC class I restricted T-cell epitopes
por: Zhang, Xue Wu
Publicado: (2013)

Immunogenic epitope prediction to create a universal influenza vaccine
por: Mintaev, R.R., et al.
Publicado: (2022)

MHC-restricted recognition of immunogenic T cell epitopes of pertussis toxin reveals determinants in man distinct from the ADP-ribosylase active site
Publicado: (1988)

Immunogenic sonodynamic therapy for inducing immunogenic cell death and activating antitumor immunity
por: Wang, Ting, et al.
Publicado: (2023)

Quantitative Prediction of the Landscape of T Cell Epitope Immunogenicity in Sequence Space
por: Ogishi, Masato, et al.
Publicado: (2019)

Multiple-Allele MHC Class II Epitope Engineering by a Molecular Dynamics-Based Evolution Protocol
por: Ochoa, Rodrigo, et al.
Publicado: (2022)

Immunogenic Cell Death and Immunomodulatory Effects of Cabozantinib
por: Scirocchi, Fabio, et al.
Publicado: (2021)

T-Cell Epitope Prediction: Rescaling Can Mask Biological Variation between MHC Molecules
por: MacNamara, Aidan, et al.
Publicado: (2009)

Prediction and validation of murine MHC class I epitopes of the recombinant virus VSV-GP
por: Vijver, Saskia V., et al.
Publicado: (2023)

Molecular Dynamics Simulations to Provide Insights into Epitopes Coupled to the Soluble and Membrane-Bound MHC-II Complexes
por: Bello, Martiniano, et al.
Publicado: (2013)

Experimental Validation of Multi-Epitope Peptides Including Promising MHC Class I- and II-Restricted Epitopes of Four Known Leishmania infantum Proteins
por: Agallou, Maria, et al.
Publicado: (2014)

Abscopal Effects of Local Radiotherapy Are Dependent on Tumor Immunogenicity
por: Lai, Jin-Zhi, et al.
Publicado: (2021)

Investigation of pre-existing reactivity to biotherapeutics can uncover potential immunogenic epitopes and predict immunogenicity risk
por: Bivi, Nicoletta, et al.
Publicado: (2019)

Preoperative Systemic Immune–Inflammation Index (SII) as a Superior Predictor of Long-Term Survival Outcome in Patients With Stage I–II Gastric Cancer After Radical Surgery
por: He, Kang, et al.
Publicado: (2022)

Hydrophobicity identifies false positives and false negatives in peptide-MHC binding
por: Solanki, Arnav, et al.
Publicado: (2022)

Modulation of CD8(+) T cell responses to AAV vectors with IgG-derived MHC class II epitopes
por: Hui, Daniel J, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_g3ccvdtift95vs6clv07i0omkm